Last reviewed · How we verify
NCT03631485
Exploring the Mental Health of Parents Having Children With Cancer
trial testing Exposure_having children with cancer in Resilience of Parents Having Children With Cancer in 181 participants. Completed in 27 November 2018.
27 November 2018
Quick facts
| Lead sponsor | The University of Hong Kong |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 181 |
| Start date | 27 August 2018 |
| Primary completion | 27 November 2018 |
| Estimated completion | 27 November 2018 |
| Sites | 1 location across Hong Kong |
Drugs / interventions tested
- Exposure_having children with cancer
Conditions studied
- Resilience of Parents Having Children With Cancer — all drugs for Resilience of Parents Having Children With Cancer →
Sponsor
The University of Hong Kong
Who can join
Eligibility, any sex, with Resilience of Parents Having Children With Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Caring for children with cancer is described as life-changing experience and overwhelming stress for parents. Poor quality of life and mental health problems such as depression and anxiety were found in this population. The psychological status of them is still waited to be improved. As a dominant term in positive psychology, resilience is commonly regarded as the ability to move forward or keep normal under adversity. It was proved to be associated with psychological outcomes in adolescents and chronic illness patients, enhanced resilience usually along with improved mental health, while little evidence was available in the parents of children with cancer. A cross-sectional study will be conducted to explore the level of resilience and psychological outcomes such as quality of life, depression, anxiety and well-being in parents of children with cancer using questionnaires. Such results will be compared with normal population to help evaluate the psychological status of those parents. The relationship between resilience and these psychological outcomes will also be examined. Lower resilience and higher resilience of the parents will be determined by the lowest and highest quartile of The Connor-Davidson Resilience Scale (CD-RISC) scores. Subsequently, a qualitative study will be conducted to explore the experience of those parents with lower resilience and higher resilience. It is anticipated that risk parents of children with cancer could be identified from the inferior outcomes of resilience and psychological outcomes. Both the results of cross-sectional study and qualitative study will guide the development of interventions designed to enhance resilience and promote positive psychological outcomes among targeted parents of children with cancer under risk.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
The Lived Experience of Resilience in Parents of Children With Cancer: A Phenomenological Study.
Luo Y, Li HCW, Xia W, Cheung AT, et al · · 2022 · cited 11× · PMID 35707743 · DOI 10.3389/fped.2022.871435 -
Relationships between resilience and quality of life in parents of children with cancer.
Luo YH, Li WHC, Cheung AT, Ho LLK, et al · · 2022 · cited 11× · PMID 33522296 · DOI 10.1177/1359105321990806
Verify or expand the search:
- PubMed search for NCT03631485
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other The University of Hong Kong trials
Trials by the same sponsor.
- NCT05981430 — Fecal Microbiota Transplantation for Decolonization of Carbapenem-resistant Enterobacteriaceae · NA · not yet recruiting
- NCT07478757 — Assessing the Effectiveness of Low-Dose Computed Tomography in Lung Cancer Screening for High-Risk Smokers: A Randomized · NA · not yet recruiting
- NCT07448649 — Chatbot-Assisted Advance Care Planning Education for Family Members · NA · not yet recruiting
- NCT07484932 — TRTRM (ACTTOP) -Guided Dosing Strategy in Older Patients With Cancer · NA · not yet recruiting
- NCT07531589 — BrainLive Connect: Non-professional Delivered CST for People Living With Dementia · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03631485 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The University of Hong Kong
- Last refreshed: 30 May 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03631485.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing